Episode 297 showcases our hosts Dr Jake Sloane & David Segal

With political issues and the economic climate changing almost every day, we're publishing this episode out of sync with our usual Friday podcast. What we recorded just 4 weeks ago dated quite a lot and so we decided to record a second part to this episode to also address the tariff situation, the stock market volatility and what these mean for aesthetic clinics.

• Part 1 (this episode) is free and available to listen to on your favourite podcast app
• Part 2 (also out now!) is exclusive for subscribers to our Patreon (CLICK HERE TO TRIAL OUR PATREON FOR FREE FOR 1 MONTH!)

In Chapter 11 (Part 1) of 'What's Trending in Aesthetics,' we reflect on the introduction of another new toxin into the Australian market. We first tackle how clinics will need to understand both the clinical but also financial implications of this. We discuss the challenges of introducing new products into your business, particularly focusing on toxins and fillers.

We highlight the vital importance of:

• Critical analysis when it comes to understanding clinical studies
• Transparent communication with patients if you change their usual product to something else
• Pricing strategies
• Understanding the nuances of different toxin and filler products.

We also touch on the importance of clinical photography, scheduling routine reviews of patients, the potential pitfalls of packaging treatments and the perception of 'top-ups.'

We conclude with practical advice on balancing margins and cash flow when making business decisions when it come to purchasing and pricing products.

00:00 Introduction and Personal Updates 00:25 Workshop Insights and Business Literacy 02:19 Financial Health and Business Strategies 07:26 Engagement and Community Building 10:00 Pricing and Introducing New Products 15:39 Navigating Industry Challenges 34:16 Critical Analysis of Medical Papers 34:49 Understanding Non-Inferiority Studies 35:42 Communicating with Patients About New Products 36:39 Conducting Internal Studies and Trials 37:37 Evaluating Toxin Performance and Patient Feedback 39:18 Challenges with New Toxins 45:42 Considerations for Fillers 50:14 Pricing and Packaging Strategies 56:45 Avoiding Free Top-Ups and Setting Expectations 01:01:09 Valuing Skills Over Product Quantity 01:05:47 Final Thoughts and Practical Advice

ALL IA LINKS & CONTACT INFORMATION